Feedback / Questions
EVO756 - Evommune, Maruho
https://www.prnewswire.com/news-releases/evommune-initiates-phase-2b-trial-of-its-oral-mrgprx2-antagonist-evo756-in-adults-with-moderate-to-severe-atopic-dermatitis-302539614.html
Aug 27, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next